Translational Cancer Research

Papers
(The H4-Index of Translational Cancer Research is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Compression of superior vena cava and azygos vein by a giant mediastinal mature cystic teratoma: a case report47
Successful treatment with osimertinib for nonmucinous bronchioloalveolar carcinoma with massive bronchorrhea and respiratory failure: a case report and literature review39
A prognostic nomogram based on least absolute shrinkage and selection operator Cox regression in patients with pulmonary large-cell neuroendocrine carcinoma34
LncRNA RP11-10E18.7 cooperates with lncRNA RP11-481C4.2 to affect the overall survival of breast cancer patients: a TCGA-based retrospective study30
Diagnostic value of double low-dose targeted perfusion CT imaging for the diagnosis of invasive and preinvasive pulmonary ground-glass nodules: systematic review and meta-analysis24
Advanced non-small cell lung cancer treated with palliative systemic therapy complicated by calvarial metastasis: a case report23
Molecular basis of heterogeneity in small cell lung cancer23
First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thorn22
Efficacy of second- and third-line chemotherapy after chemotherapy with platinum doublet and immunotherapy in non-small cell lung cancer: a descriptive study20
Comprehensive analysis of exosome gene LYPD3 and prognosis/immune cell infiltration in lung cancer20
Clinical pathological characteristics correlation of H3F3A gene mutation in giant cell tumor of bone: a study of 96 cases20
Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial19
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer18
The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study18
The size and sternal involvement of chest wall resections for malignant disease predict postoperative morbidity18
MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis18
Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment17
Establishment and validation of a prognostic prediction model for glioma based on key genes and clinical factors17
Prognostic significance of B cell senescence-associated genes as risk markers in prostate adenocarcinoma17
1.7749190330505